Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.
about
Applications of nanotechnology in dermatologyQuantification of quantum dot murine skin penetration with UVR barrier impairmentTransferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.Familiar and novel reproductive endocrine disruptors: xenoestrogens, dioxins and nanoparticlesNanoparticles and nanofibers for topical drug delivery.Nanoparticles for transcutaneous vaccination.Gold nanoparticle mediated cancer immunotherapyAdvanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Drug delivery to hair follicles.Molecularly stabilised ultrasmall gold nanoparticles: synthesis, characterization and bioactivity.Gold nanoparticles and vaccine development.Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.Pluripotent stem cells: An in vitro model for nanotoxicity assessments.Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.Functionalized Gold Nanoparticles and Their Biomedical Applications.Effect of Size and Surface Charge of Gold Nanoparticles on their Skin Permeability: A Molecular Dynamics Study.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.Transdermal cellular membrane penetration of proteins with gold nanoparticles: a molecular dynamics study.Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil.Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation.A spectroscopic investigation on the interaction of a magnetic ferrofluid with a model plasma protein: effect on the conformation and activity of the protein.Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.In Vitro AuNPs' Cytotoxicity and Their Effect on Wound Healing.Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans"Aggregation behavior of pH- and thermo-responsive block copolymer protected gold nanoparticles
P2860
Q24170384-6F3885E1-6D49-4521-8459-7341C7870C62Q28390527-58F823AB-DD98-4C6C-B350-E61640C8133DQ34110128-2D4EFC4A-9016-4BBC-92FF-DBC8C9CAEB6FQ34460808-34F3263A-7513-410D-945A-317D0116F6ACQ35190470-B54154B4-6DD3-4D07-9188-34BF56516D73Q36978587-CD2491A6-FE48-411C-B987-F51F557AAE74Q37274692-AE59740B-67B3-455C-B495-5CB232A1DAB8Q37666077-89A39C5B-739E-4102-8FE1-3FF77786DFECQ37957956-58DD22BD-58FE-4194-A9EF-44DF8E6F209AQ38093232-143B8E8F-D32A-4D97-A40D-38A83B900F1AQ38112603-CAD65DFC-CF94-40C4-B2E3-A10F74E2AA2FQ38543673-BF6BC2AE-63FC-460B-A16A-F70B4329CBF4Q38716160-05383F95-460A-4907-9D12-D0690A89E316Q38848644-4BDFC5A7-A74F-455A-9BCF-A15AC4FBA4F2Q39092873-5A8A0ECB-4127-45B5-8171-0A793E92CBDBQ39203522-2257061B-48CC-422E-AEA1-E0CBC5BE9646Q42157878-43F16B41-12BB-44D8-9599-B8F1739CBE75Q47808831-0875BA56-6E70-4863-A9E1-7018DDD3DE97Q48045998-039E2FC8-AD83-4929-B766-830D3ECBEF06Q48327353-8B413628-838F-4DE8-98B2-457B49027BF0Q50910910-1089B409-491B-4C03-A3BA-D972C322BA48Q51309453-81B086E2-32A0-4265-9196-7AA7F69DD49CQ52622309-039A7A5A-07AF-41B6-A51D-B179FB1F327EQ55312929-28237C08-CE58-41ED-A4F2-172730382011Q57177419-FA138755-0393-4C2E-9EF3-1EAF4862384BQ57346604-BDFCBBF5-A432-44D5-A549-76888BED8908
P2860
Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Co-administration of protein d ...... enable percutaneous delivery.
@ast
Co-administration of protein d ...... enable percutaneous delivery.
@en
Co-administration of protein d ...... enable percutaneous delivery.
@nl
type
label
Co-administration of protein d ...... enable percutaneous delivery.
@ast
Co-administration of protein d ...... enable percutaneous delivery.
@en
Co-administration of protein d ...... enable percutaneous delivery.
@nl
prefLabel
Co-administration of protein d ...... enable percutaneous delivery.
@ast
Co-administration of protein d ...... enable percutaneous delivery.
@en
Co-administration of protein d ...... enable percutaneous delivery.
@nl
P2093
P2860
P1433
P1476
Co-administration of protein d ...... enable percutaneous delivery.
@en
P2093
Hee Sun Chung
Jianxin Wang
Meong-Cheol Shin
Victor C Yang
Yongzhuo Huang
Yoon-Shin Park
P2860
P304
P356
10.1016/J.BIOMATERIALS.2010.08.046
P577
2010-09-09T00:00:00Z